The U.S. Food and Drug Administration (FDA) stated that Moderna (MRNA.O) violated the advice of FDA professional scientists by providing substandard care to participants aged 65 and older, exposing them to an increased risk of serious illness.
2026-02-12
The U.S. Food and Drug Administration (FDA) stated that Moderna (MRNA.O) violated the advice of FDA professional scientists by providing substandard care to participants aged 65 and older, exposing them to an increased risk of serious illness.
